Year: 2018
Type: review
Abstract: Leukotrienes, a class of arachidonic acid-derived bioactive molecules, are known as mediators of allergic and inflammatory reactions and considered to be important drug targets. Although an inhibitor of leukotriene biosynthesis and antagonists of the cysteinyl leukotriene receptor are clinically used for bronchial asthma and allergic rhinitis, these medications were developed before the molecular identification of leukotriene receptors. Numerous studies using cloned leukotriene receptors and genetically engineered mice have unveiled new pathophysiological roles for leukotrienes. This Review covers the recent findings on leukotriene receptors to revisit them as new drug targets.
DOI: 10.1172/jci97946
Language: English
Subfield: Biochemistry
Domain: Life Sciences
Open Access status: bronze
Funders: Naito Foundation, Takeda Science Foundation, Japan Agency for Medical Research and Development, National Center for Global Health and Medicine, Ministry of Education, Culture, Sports, Science and Technology, Mitsubishi Foundation, University of Tokyo, Ono Pharmaceutical, Japan Society for the Promotion of Science
OpenAlex ID: W2799420115
